Designed a series of 60-second animated explainers for a complex gene therapy trial, significantly boosting patient comprehension of risks and benefits.
The Phase I/II gene therapy trial involved complex biological mechanisms, novel risks, and a lengthy, technical Informed Consent Form (ICF). Patient fatigue and low literacy made it nearly impossible for sites to ensure true informed consent.
Kayla Fulton
Emerging Biotech / Phase I/II First-in-Human
"The animated video was critical. It was the only way we could confidently explain the complex science to patients and their caregivers, setting a new, higher standard for informed consent in our cutting-edge trials."
Team behind Poppin
What we did
22% increase in patient scores on the ICF knowledge assessment; 45% reduction in time spent by the site coordinator on basic protocol explanations; Accelerated enrolment by 6 weeks.
8
Pages
4
CMS Layouts
5
Breakpoints
Project approach
As part of the Informed Consent Experience Suite, we created short, narrative-driven animated videos (live-action videos: 60–180 second assets) to visually explain the gene delivery method and potential risks. These assets were deployed at the pre-screening stage, acting as a powerful adjunct to the paper ICF. This strategy helps stakeholders, as video is an effective way to convey complex information.
%402x.svg)
%402x.svg){kind=icon}
%402x%20(dark).svg){kind=icon}
%402x%20(dark).svg){kind=icon}
%402x.svg){kind=icon}